Counterfeit Drugs -
Using Surface Analysis to Identify Fake Pharmaceuticals

As counterfeit drugs are becoming increasingly available (the US-based Centre for Medicines in the Public Interest predicts that counterfeit drug sales will be worth an estimated US$75 billion globally in 2010), the technology that is used to manufacture these fake medicines is becoming more and more sophisticated.

CERAM Surface and Materials Analysis, together with GlaxoSmithKline, has developed a method of identifying counterfeit tablets, when compared to genuine drugs, by utilising techniques such as XPS and ToFSIMS.

Further to normal methods of looking at composition, this method concentrates on process and the manufacturing route of the drugs, the end result being that previously undetectable chemical copies of pharmaceuticals can be identified.

White Paper: Surface Analysis Exposes Counterfeit Medicines

The White Paper can be downloaded from our parent company's website by registering on the site.